Crosslinking of amyloid-β peptide to brain acetylcholinesterase

Molecular and Chemical Neuropathology

Volumn 33, Issue 1, 1998, Pages 39-49

  Opazo, Carlos ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Acetylcholinesterase; Alzheimer disease; Amyloid ; A AChE complex

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CROSS LINKING REAGENT; DIMER; MONOMER; OLIGOMER; SUBERIC ACID BIS(N HYDROXYSUCCINIMIDE) ESTER; TETRAMER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION;

EID: 0031891944     PISSN: 10447393     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815858     Document Type: Article

References (38)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Alvarez A., Bronfman F., Perez C. A., Vicente M., Garrido J., and Inestrosa N. C. (1995) Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides. Neurosci. Lett. 201, 49-52.
3. Alvarez A., Opazo C., Alarcón R., Garrido J., and Inestrosa N. C. (1997) Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272, 348-361.
4. Barrow C. J., Yasuda A., Kenny P. T. M., and Zagorski M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225, 1075-1093.
5. Brunden K. R., Richter-Cook N. J., Chaturverdi N., and Frederickson R. C. A. (1993) pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J. Neurochem. 61, 2147-2154.
6. Deprez P. and Inestrosa N. C. (1995) Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase J. Biol. Chem. 270, 11,043-11,046.
7. Ellman G. L., Courtney K. D., Andres V., and Featherstone R. M. (1961) A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
8. Geula C. and Mesulam M.-M. (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer' disease. Brain Res. 498, 185-189.
9. Inestrosa N. C., Roberts W. L., Marshall T. L., and Rosenberry T. L. (1987) Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterase in other tissues. J. Biol. Chem. 262, 4441-4444.
10. Inestrosa N. C., Alvarez A., Perez C. A., Moreno R. D., Vicente M., Linker C., Casanueva O. I., Soto C., and Garrido, J. (1996a) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
11. Inestrosa N. C., Alvarez A., and Calderón F. (1996b) Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid β-peptide into Alzheimer's filaments. Mol. Psychiatry 1, 359-361.
12. Inestrosa N. C., Alvarez A., Garrido J., Calderón E, Bronfman F. C., Dajas F., Gentry M. K., and Doctor B. P. (1997) Acetylcholinesterase promotes Alzheimer's β-amyloid fibril formation, in Alzheimer's Disease: Biology, Diagnosis and Therapeutics (Iqbal, K., Winblad, B., Nishimura, T., Takeda, M., and Wisniewski, H. M., eds.), Wiley, UK, pp. 499-508.
13. Iversen L. L., Mortishire-Smith R. J., Pollack S. J., and Sherman M. S. (1995) The toxicity in vitro of β-amyloid protein. Biochem. J. 311, 1-16.
14. Kalaria R. N., Kroon S. N., Grahovac I., and Perry G. (1992) Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience 51, 177-184.
15. Kalaria R. N., Golde T., Kroon S. N., and Perry G. (1993) Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease. Am. J. Pathol. 143, 886-893.
16. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
17. Lwebuga-Mukasa J. M., Lappi S., and Taylor P. (1976) Molecular forms of acetylcholinesterase from Torpedo californica: their relationship to synaptic membranes. Biochemistry 15, 1425-1434.
18. Markwell M. A. A. (1982) A new solid-state reagent to iodinate proteins: conditions for the efficient labelling of antiserum. Anal. Biochem. 125, 427-432.
19. Morán, M. A., Mufson, E. J., and Gómez-Ramos, P. (1993) Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brain. Acta Neuropathol. 85, 362-369.
20. Muller-Hill B. and Beyreuther K. (1989) Molecular biology of Alzheimer disease. Annu. Rev. Biochem. 58, 287-307.
21. Munch G., Mayer S., Michaelis J., Hipkiss A. R., Riederer P., Muller R., Neumann R., Schinzel R., and Cunningham A. M. (1997) Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide. Biochim. Biophys. Acta 1360, 17-29.
22. Namba Y., Tomonaga M., Kawaski H., Otomon E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541, 163-166.
23. Perry G. and Smith M. A. (1993) Senile plaques and neurofibrillary tangles: what roles do they play in Alzheimer's disease? Clin. Neurosci. 1, 199-203.
24. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. G., and Cotman C. W. (1995) Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
25. Reyes A. E., Perez D. R., Alvarez A., Garrido J., Gentry M. K., Doctor B. P., and Inestrosa N. C. (1997) A monoclonal antibody against acetykholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. Biochem. Biophys. Res. Commun. 232, 652-655.
26. Sakamoto, C., Williams, J. A., Wong, K. Y., and Goldfine, I. D. (1983) The CCK receptor on pancreatic plasma membranes: binding characteristics and covalent cross-linking. FEBS Lett. 151, 63-66.
27. Schagger H. and von Jagow G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel elecrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
28. Selkoe D. J. (1994) Normal and abnormal biology of the β-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.
29. Selkoe D. J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18,295-18,298.
30. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S-D., Stern D., Sayre L. M., Monnier V. M., and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimer's disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710-5714.
31. Smith M. A., Dunbar C. E., Miller E. J., and Perry G. (1996) Trypsin interaction with the senile plaques of Alzheimer disease is mediated by β-protein precursor. Mol. Chem. Neuropathol. 27, 145-154.
32. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Susuki S., Hassell J., and Wight T. N. (1988) The presence of heparan sulfate proteoglycan in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
33. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., and Morgan D. G. (1994) An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron 12, 219-234.
34. Soto C., Branes M. C., Alvarez J., and Inestrosa N. C. (1994) Structural determinants of the Alzheimer's amyloid β-peptide. J. Neurochem. 63, 1191-1198.
35. Soto C., Castaño E., Frangione B., and Inestrosa N. C. (1995) The α-helical to β-strand transition in the N-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270, 3063-3067.
36. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., and Cerami A. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91, 4766-4770.
37. Wood C. L. and O'Dorisio M. S. (1985) Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts. J. Biol. Chem. 260, 1243-1247.
38. Yen D. S., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao E., Nagashima M., Morser J., Migheli A., Nawroth M., Stern D., and Schmidt A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-692.